Dr. Ralph Sacco, neurologist-in-chief at Jackson Memorial Hospital and the Miller Professor of Neurology, Epidemiology and Human Genetics at the Univeristy of Miami, joins host Dr. Anthony Alessi to discuss the FDA-approved treatment approaches for acute ischemic stroke, and what proportion of stokes each year are now treated with IV rTPA. Additionally, Dr. Sacco reviews the newly designated primary stroke centers throughout the United States, and how these have helped expand the treatement of stroke and organized healthcare professionals to provide the right treatment program for their patients in hospitals.
